HealthEquity, Inc. (NASDAQ:HQY) Expected to Earn Q2 2025 Earnings of $0.52 Per Share

HealthEquity, Inc. (NASDAQ:HQY) – Equities researchers at Zacks Research lifted their Q2 2025 earnings estimates for HealthEquity in a research note issued to investors on Wednesday, June 26th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.52 per share for the quarter, up from their prior estimate of $0.51. The consensus estimate for HealthEquity’s current full-year earnings is $2.12 per share. Zacks Research also issued estimates for HealthEquity’s Q3 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.56 EPS, Q2 2026 earnings at $0.65 EPS, Q3 2026 earnings at $0.66 EPS and FY2027 earnings at $3.52 EPS.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.08. The business had revenue of $287.60 million for the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%.

HQY has been the subject of a number of other reports. Robert W. Baird lifted their price objective on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. BTIG Research lifted their price objective on shares of HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Bank of America lifted their price objective on shares of HealthEquity from $97.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, June 4th. JPMorgan Chase & Co. boosted their target price on shares of HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research report on Tuesday, April 2nd. Finally, JMP Securities boosted their target price on shares of HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a research report on Tuesday, June 4th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $101.67.

HealthEquity Trading Up 0.5 %

HQY stock opened at $86.62 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The company has a fifty day moving average price of $81.14 and a two-hundred day moving average price of $78.32. HealthEquity has a one year low of $61.32 and a one year high of $88.26. The stock has a market cap of $7.54 billion, a price-to-earnings ratio of 94.15, a price-to-earnings-growth ratio of 1.45 and a beta of 0.55.

Insider Buying and Selling

In related news, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Stephen Neeleman sold 2,080 shares of the business’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $85.01, for a total value of $176,820.80. Following the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at approximately $7,694,680.15. The disclosure for this sale can be found here. Insiders sold 34,806 shares of company stock valued at $2,888,383 over the last quarter. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of HQY. Envestnet Asset Management Inc. raised its holdings in HealthEquity by 41.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 84,617 shares of the company’s stock valued at $6,181,000 after buying an additional 24,685 shares during the last quarter. Mariner LLC raised its holdings in HealthEquity by 2.4% in the 3rd quarter. Mariner LLC now owns 14,983 shares of the company’s stock valued at $1,095,000 after buying an additional 345 shares during the last quarter. Natixis Advisors L.P. raised its holdings in HealthEquity by 7.2% in the 3rd quarter. Natixis Advisors L.P. now owns 17,664 shares of the company’s stock valued at $1,290,000 after buying an additional 1,180 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in HealthEquity by 22.5% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 6,201 shares of the company’s stock valued at $453,000 after buying an additional 1,141 shares during the last quarter. Finally, Gotham Asset Management LLC bought a new position in HealthEquity in the 3rd quarter valued at approximately $1,103,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.